Related Experiment Video

Updated: Aug 7, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers

Ian J Davis1, Jessica J Kim, Fatih Ozsolak

  • 1Melanoma Program in Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Cancer Cell
|June 13, 2006
PubMed

Insights

Clear cell sarcoma (CCS) hijacks the Ewing's sarcoma gene (EWS) to activate the MITF oncogene, driving tumor growth and melanocytic features. This mechanism highlights a broader role for MiT family dysregulation in various cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Clear cell sarcoma (CCS) is characterized by a specific EWS-ATF1 gene fusion.
  • CCS exhibits melanocytic features, suggesting a link to melanocyte differentiation pathways.

Purpose of the Study:

  • To elucidate the molecular mechanism by which EWS-ATF1 drives CCS.
  • To investigate the role of MITF in CCS pathogenesis and its relationship with other MiT family members.

Main Methods:

  • Chromatin immunoprecipitation to assess EWS-ATF1 binding to the MITF promoter.
  • Knockdown and rescue experiments in vitro and in vivo.
  • Analysis of tumor lines from CCS and pediatric renal carcinoma.

Main Results:

  • EWS-ATF1 directly binds the MITF promoter, inducing MITF expression and mimicking melanocyte-stimulating hormone (MSH) signaling.
  • MITF is essential for CCS cell survival, differentiation, and the oncogenic function of EWS-ATF1.
  • MITF and TFE3 can reciprocally rescue each other in different tumor contexts.

Conclusions:

  • The EWS-ATF1 fusion protein oncogenically activates MITF, a key driver of CCS.
  • Dysregulation of the MiT family, including MITF and TFE3, represents a common oncogenic strategy across diverse human cancers.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...